Jeffrey E. Jacob's most recent trade in Panbela Therapeutics Inc. was a trade of 8,333 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 27, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Panbela Therapeutics Inc. | Jeffrey E. Jacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 8,333 | 8,333 | - | - | Stock Option (right to buy) | |
| Panbela Therapeutics Inc. | Jeffrey E. Jacob | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2022 | 49,500 | 49,500 | - | - | Warrants (right to buy) | |
| Panbela Therapeutics Inc. | Jeffrey E. Jacob | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2022 | 33,000 | 294,931 (4%) | 0% | - | Common Stock |